Sanofi-Aventis allegedly gave millions of dollars to physicians groups that lobbied against the approval of generic versions of the French drugmaker's blockbuster blood-thinner Lovenox, according to a report released this week by Sens. Max Baucus (D-Mont.) and Chuck Grassley (R-Iowa).
The report alleges that the Society of Hospital Medicine, the North American Thrombosis Forum and Duke University medical professor Dr. Victor Tapson used the Food and Drug Administration's citizen petition process to request that the agency delay generic versions of Lovenox because of safety concerns.
Sanofi reportedly gave $2.6 million to the Society of Hospital Medicine from 2007 to 2010; $2.3 million to the North American Thrombosis Forum from 2007 to 2010; and $260,000 to Tapson. None disclosed financial ties to Sanofi in letters to the FDA, according to the report.